Chabiotech Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chabiotech Co Ltd with three other
miscellaneous service companies in Asia:
BGI Genomics Co Ltd
sales of 1.71 billion Chinese Renmimbi [US$272.75 million]
of which 54%
was Reproductive Health Service),
(52.70 billion Japanese Yen [US$491.72 million]
of which 47%
was Domestic CRO Business), and
Takara Bio Inc
based in Japan
(29.73 billion Japanese Yen [US$277.37 million]
of which 92%
was Bio support).
Chabiotech Co Ltd reported sales of 449.26 billion Korean Won (US$421.86 million)
December of 2016.
increase of 14.1%
versus 2015, when the company's sales were 393.78 billion Korean Won.